Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 32, 2019 - Issue 21
Submit an article Journal homepage
1,405
Views
2
CrossRef citations to date
0
Altmetric
Original Article

The association of second trimester biomarkers in amniotic fluid and fetal outcome

Irene SterpuDepartment of Clinical Science and Education, Karolinska Institute, Women’s Clinic, Sodersjukhuset, Sweden; View further author information
,
Peter AnfelterDepartment of Clinical Science and Education, Karolinska Institute, Women’s Clinic, Sodersjukhuset, Sweden; View further author information
,
Susan WrayDepartment of Molecular and Cellular Physiology, Institute of translational medicine, University of Liverpool, Liverpool, United Kingdom; View further author information
,
Helena KaiholaDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, SwedenView further author information
,
Helena ÅkerudDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, SwedenView further author information
&
Eva Wiberg-ItzelDepartment of Clinical Science and Education, Karolinska Institute, Women’s Clinic, Sodersjukhuset, Sweden; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-4835-9616View further author information
ORCID Icon
Pages 3627-3632 | Received 13 Feb 2018, Accepted 22 Apr 2018, Published online: 06 May 2018

References

  • Socialstyrelsen. Available from: http://www.socialstyrelsen.se/statistik/statistikdatabas/graviditeter-forlossningarochnyfodda
  • WHO; Maternal, newborn, child and adolescent health. Available from: http://www.who.int/maternal_child_adolescent/epidemiology/stillbirth/en/
  • Spencer K, Souter V, Tul N, et al. A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 1999;13(4):231–237.
  • Virgiliou C, Gika HG, Witting M, et al. Amniotic fluid and maternal serum metabolic signatures in the second trimester associated with preterm delivery. J Proteome Res. 2017;16(2):898–910.
  • Liu Y, Liu Y, Zhang R, et al. Early- or mid-trimester amniocentesis biomarkers for predicting preterm delivery: a meta-analysis. Ann Med. 2017;49(1):1–10.
  • Scioscia M, Vimercati A, Selvaggi LE, et al. Inositol phosphoglycan putative insulin mediator in human amniotic fluid. J Matern Fetal Neonatal Med. 2006;19(1):9–12.
  • Boué A, Muller F, Nezelof C, et al. Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis. Hum Genet. 1986;74(3):288–297.
  • Giannubilo SR, Tiano L, Ciavattini A, et al. Amniotic coenzyme Q10: is it related to pregnancy outcomes? Antioxid Redox Signal. 2014;21(11):1582–1586.
  • Quenby S, Pierce SJ, Brigham S, et al. Dysfunctional labour and myometrial lactic acidosis. Obstet Gynecol. 2004;103(6):1344.
  • Lash GE, Cartwright JE, Whitley GS, et al. The effects of angiogenic growth factors on extra villous trophoblast invasion and motility. Placenta. 1999;20(8):661–667.
  • Kleinrouweler CE, Wiegerinck MM, Ris-Stalpers C, et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG. 2012;119(7):778–787.
  • Akerud H, Ronquist G, Wiberg-Itzel E. Lactate distribution in culture medium of human myometrial biopsies incubated under different conditions. Am J Physiol Endocrinol Metab. E1414. 2009;297(6):E1414–E1419.
  • Wiberg-Itzel E, Pettersson H, Cnattingius S, et al. Association between lactate concentration in amniotic fluid and dysfunctional labor. Acta Obstet Gynecol Scand. 2008;87(9):924–928.
  • Wiberg-Itzel E, Pettersson H, Andolf E, et al. Lactate concentration in amniotic fluid: a good predictor of labor outcome. Eur J Obstet Gynecol Reprod Biol. 2010;152(1):34–38.
  • Genbacev O, Zhou Y, Ludlow JW, et al. Regulation of human placental development by oxygen tension. Science. 1997;277(5332):1669–1672.
  • Caniggia I, Winter J, Lye SJ, et al. Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia. Placenta. 2000;21(Suppl A):S25–SS30.
  • Chen D, Zheng J. Regulation of placental angiogenesis. Microcirculation. 2014;21(1):15–25.
  • Tranquilli AL, Bezzeccheri V, Giannubilo SR, et al. Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2004;113(1):17–20.
  • Hofmeyr GJ, Novikova N. Management of reported decreased fetal movements for improving pregnancy outcomes. Cochrane Database Syst Rev. 2012;4(4):CD009148.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.